Using Of Chitosan in Alveolar Ridge Preservation

November 15, 2023 updated by: Prince Sattam Bin Abdulaziz University

Using Of Chitosan in Alveolar Ridge Preservation: Randomized Clinical Trial.

The goal of this clinical trial is to assess the efficacy of chitosan as a socket preservation material after tooth extraction in compare to the standard treatment. The study will include patients who exhibit hopeless tooth without any periodontal infection. Smokers, history of allergy, patients with major medical issue and pregnant women will be excluded from the study. The main question[s] to answer is : is there a significant difference in bone density and dimension between the test and control groups after tooth extraction or not.

Participants will be asked to do CBCT scan and take upper and lower impressions before extraction and after three month from extraction. Then, the patients will randomly assigned to one from these groups: There will be a total of three groups (10 patients for each), first group will be treated using mixed of chitosan and allograft, second group will be treated using allograft alone and the last group will be used as control. All patients will be treated in accordance with the 2013 Declaration of Helsinki.

Study Overview

Detailed Description

To evaluate the tissue response, intraoral impressions and X-ray will be taking from each patient before extraction and three months after. Also, Cone-beam computed tomography (CBCT) will be taking to measure the bone growth at base line and three months after surgery is done. For measurement, each socket will be vertically divided into 3 equal areas: coronal, middle, and apical. Regenerated bone density will be assessed in each area, in both control and intervention groups.

Data then can be analyzed using SPSS ver. 11 (SPSS Inc., Chicago,USA). P-values less than 0.05 were considered as significant.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Central
      • Riyadh, Central, Saudi Arabia, 16273
        • Prince Sattam Bin Abdulaziz University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Clinical diagnosis of hopeless tooth.
  • Healthy patient.
  • Healthy gingiva without any periodontal disease.
  • Patient is welling to come after three months.

Exclusion Criteria:

  • Smokers.
  • History of allergy.
  • pregnant women.
  • patient with systemic disease.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Chitosan
group will be treated using chitosan as a replacement of bone particles with collagen membrane after tooth extraction
to replace the bone at the extraction site we will put either chitosan or allograft particles
Other Names:
  • chitosan
Active Comparator: Allograft
after extraction, the group will be treated using the gold standard protocol which is the (allograft) bone particles with collagen membrane.
to replace the bone at the extraction site we will put allograft particles
Other Names:
  • gold standard treatment
Placebo Comparator: placebo
the extraction will be done without placing any bone material inside
hopeless tooth will be extracted without any intervention
Other Names:
  • normal extraction

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bone Hight
Time Frame: 3 months
Changes in vertical dimension in mm from baseline using scans section from CBCT.
3 months
Bone volume
Time Frame: 3 months
Changes in horizontal width in mm from baseline using scans section from CBCT.
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tissue healing
Time Frame: 3 months
changes in scale of redness of gingiva from baseline
3 months
Dry socket
Time Frame: 3 months
the No of exposed bone from baseline until healing
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 18, 2023

Primary Completion (Estimated)

December 1, 2023

Study Completion (Estimated)

March 20, 2024

Study Registration Dates

First Submitted

July 9, 2023

First Submitted That Met QC Criteria

November 15, 2023

First Posted (Actual)

November 18, 2023

Study Record Updates

Last Update Posted (Actual)

November 18, 2023

Last Update Submitted That Met QC Criteria

November 15, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bone Augmentation

Clinical Trials on extraction with chitosan particles as a replacement for bone graft with collagen membrane

3
Subscribe